Caribou selected a de-risked target and modality to take on multiplexed editing

BioCentury’s roundup of translational innovations also includes causal biology for a heart condition, and the biological foundational model Evo 2

BioCentury’s roundup of translational innovations also includes a human hypothalamus atlas from Novo and collaborators, and four papers with links to newcos

Oligo delivery to the kidney, and two emerging use cases for T cell engagers, each get newcos; most with mega-

Back to School 2024 identifies the target classes emerging in inflammation and immunology, and the technologies used to find them

BioCentury’s roundup of translational innovations

The company combines bispecific T cell engagers with allogeneic T cells engineered to be dependent on them

BioCentury’s roundup of translational innovations

Launched in March with $150M, Clasp is designing T cell-engaging bispecifics to better fit the immune synapse